Pantoloc (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on conditions related to excess gastric acid secretion.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining.
• Erosive esophagitis: accelerates ulcer healing in the esophagus.
• Peptic ulcer disease: supports ulcer closure and reduces recurrence risk.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to this pump, it blocks the final step of acid production, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: increased intestinal gas.
• Constipation: occasional bowel habit change.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps or irregular heartbeat.
• Fracture risk: reduced bone mineral density with long‑term use.

When prescribing Pantoloc, clinicians should consider several safety aspects.

• Assess renal function: dose adjustment may be needed in severe impairment.
• Monitor for infections: prolonged acid suppression can increase risk of gastrointestinal infections.
• Evaluate bone health: long‑term therapy may affect calcium absorption.
• Review concomitant medications: potential for altered drug absorption.
• Pregnancy and lactation: use only if clearly needed.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Ketoconazole or itraconazole: reduced antifungal absorption.
• Atazanavir: markedly decreased antiviral exposure.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: possible alteration of INR values.
• Methotrexate: increased serum concentrations, especially in renal impairment.
• Digoxin: modest increase in serum levels.
• Iron supplements: decreased iron absorption when taken simultaneously.